Related references
Note: Only part of the references are listed.Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: The spontaneously hypertensive rat
Li-Li Liu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
The immune-mediated alteration of serotonin and glutamate:: towards an integrated view of depression
N. Mueller et al.
MOLECULAR PSYCHIATRY (2007)
MDMA (Ecstasy) suppresses the innate IFN-γ response in vivo:: A critical role for the anti-inflammatory cytokine IL-10
Noreen T. Boyle et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Nortriptyline delays disease onset in models of chronic neurodegeneration
Hongyan Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Noradrenaline deficiency in brain increases β-amyloid plaque burden in an animal model of Alzheimer's disease
Sergey Kalinin et al.
NEUROBIOLOGY OF AGING (2007)
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease
Jennifer L. Whitwell et al.
BRAIN (2007)
Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide-induced apoptosis in hippocampus-derived adult neural stem cells
Yu-Yin Huang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex
Weldon E. Horner et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Inflammatory processes in Alzheimer's disease
Michael T. Heneka et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
The role of inflammation in CNS injury and disease
SM Lucas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Antidepressants suppress production of the Th1 cytokine interferon-γ, independent of monoamine transporter blockade
Michael Diamond et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Age and neuroinflammation: A lifetime of psychoneuroimmune consequences
Jonathan P. Godbout et al.
NEUROLOGIC CLINICS (2006)
Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release
Peter Thornton et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Pharmacological strategies for the regulation of inducible nitric oxide synthase: Neurodegenerative versus neuroprotective mechanisms
Ravinder Pannu et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat
Chad J. Swanson et al.
NEUROPHARMACOLOGY (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
Norepinephrine protects cortical neurons against micro glial-induced cell death
JLM Madrigal et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Interleukin-1 and neuronal injury
SM Allan et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Negative regulation of Toll-like receptor-mediated immune responses
FY Liew et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cytokines and major depression
OJG Schiepers et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Noradrenergic mechanisms in neurodegenerative diseases: a theory
MR Marien et al.
BRAIN RESEARCH REVIEWS (2004)
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls
EJ Burton et al.
BRAIN (2004)
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression
MM Katz et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial
DK Kelsey et al.
PEDIATRICS (2004)
Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3
QJ Huang et al.
NATURE IMMUNOLOGY (2004)
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4
EM Pålsson-McDermott et al.
IMMUNOLOGY (2004)
Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat
NJ Mulcahy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Intrinsic regulation of brain inflammatory responses
E Galea et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)
Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention
B Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Neuroinflammatory processes in Parkinson's disease
S Hunot et al.
ANNALS OF NEUROLOGY (2003)
Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease
S Rotshenker
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study
CE Beyer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in Attention Deficit/Hyperactivity Disorder
FP Bymaster et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Effects of norepinephrine on rat cultured microglial cells that express α1, α2, β1 and β2 adrenergic receptors
K Mori et al.
NEUROPHARMACOLOGY (2002)
Noradrenergic regulation of inflammatory gene expression in brain
DL Feinstein et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Endotoxemia prevents the cerebral inflammatory wave induced by Intraparenchymal lipopolysaccharide injection: Role of glucocorticoids and CD14
S Nadeau et al.
JOURNAL OF IMMUNOLOGY (2002)
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration
MM Iravani et al.
NEUROSCIENCE (2002)
Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo
T Dehmer et al.
JOURNAL OF NEUROCHEMISTRY (2000)
β-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NFκB-inducing kinase-dependent signaling mechanism
KT Akama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
